Skip to main content
Equibles

BARCLAYS PLC

Position in AMGN — Amgen Inc

CIK 312069 LONDON, X0
Back to AMGN Full portfolio

Position in AMGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$480,414,824
-$57,779,508 QoQ
Shares Held
1,326,673
-13.3% QoQ
Ownership
0.245%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#48
of 3,131 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMGN Over Time

Shares Held

Position Value (USD)

Derivatives in AMGN

reported options exposure · as of Jun 30, 2026
CallValue
$83,649,720
CallShares
231,000
PutValue
$30,925,048
PutShares
85,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $8,073,972,287 across 18 Drug Manufacturers - General names. AMGN ranks #7 (6.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 1,143,891 $1,372,017,294
2 ABBV
AbbVie Inc.
 5,015,515 $1,262,104,193
3 AZN
Astrazeneca PLC
 6,592,403 $1,250,051,454
4 JNJ
Johnson & Johnson
 4,651,595 $1,181,365,579
5 MRK
Merck & Co., Inc.
 6,793,897 $873,015,763
6 GILD
Gilead Sciences, Inc.
 5,113,242 $646,006,993
7 AMGN
Amgen Inc
This page 		1,326,673 $480,414,824
8 PFE
Pfizer Inc
 16,746,801 $403,262,965

All Filings in AMGN

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $83,649,720 231,000
2026-06-30 $30,925,048 85,400
2026-06-30 $480,414,824 1,326,673
2026-03-31 $75,471,825 214,500
2026-03-31 $14,355,480 40,800
2026-03-31 $538,194,332 1,529,613
2025-12-31 $9,688,376 29,600
2025-12-31 $628,597,216 1,920,495
2025-12-31 $3,534,948 10,800
2025-09-30 $959,480 3,400
2025-09-30 $7,196,100 25,500
2025-09-30 $760,627,769 2,695,350
2025-06-30 $120,144,063 430,300
2025-06-30 $28,870,314 103,400
2025-06-30 $668,071,348 2,392,720
2025-03-31 $51,592,680 165,600
2025-03-31 $12,742,395 40,900
2025-03-31 $797,441,820 2,559,595
2024-12-31 $33,361,920 128,000
2024-12-31 $13,475,088 51,700
2024-12-31 $516,839,995 1,982,965
2024-09-30 $748,122,642 2,321,848
2024-09-30 $113,192,373 351,300
2024-09-30 $25,390,148 78,800
2024-06-30 $186,845,100 598,000
2024-06-30 $588,516,757 1,883,555
2024-03-31 $122,939,968 432,400
2024-03-31 $56,437,520 198,500
2024-03-31 $1,234,705,373 4,342,661
2023-12-31 $36,952,966 128,300
2023-12-31 $839,931,699 2,916,227
2023-12-31 $75,346,032 261,600
2023-09-30 $411,327,772 1,530,465
2023-09-30 $31,767,432 118,200
2023-09-30 $118,200,648 439,800
2023-06-30 $18,516,468 83,400
2023-06-30 $375,255,315 1,690,187
2023-06-30 $41,073,700 185,000
2023-03-31 $193,386,702 799,945
2023-03-31 $8,026,100 33,200
2023-03-31 $47,286,300 195,600
2022-12-31 $452,143,425 1,721,533
2022-12-31 $16,703,904 63,600
2022-12-31 $9,087,344 34,600
2022-09-30 $227,036,177 1,007,259
2022-06-30 $205,231,577 843,533
2022-03-31 $305,637,505 1,263,905
2021-12-31 $682,509,035 3,033,778
2021-09-30 $435,798,954 2,049,372
2021-06-30 $14,430,000 59,200

Report a Problem

Category
Description
Email (optional, for follow-up)